For the Inventor, By the Inventor

Enter assignee name

Seongnam, South Korea

Oscotec Inc.

Calculating rank

USPTO Granted Patents = 16

% Expired Patents = 37.5

CIPO Patents = 2

EPO Patents = 10

Forward Citations = 26

Loading Chart...

Loading Chart...

55 inventors (with patents filed for the assignee):

Se-Won Kim (11 out of 16 patents)

Jang-Sik Choi (7 out of 7 patents)

Jaekyoo Lee (7 out of 12 patents)

4. Jung-Keun Kim (7 out of 7 patents)

5. Seon-Yle Ko (7 out of 7 patents)

6. Jung-Ho Kim (5 out of 30 patents)

7. Ho-Juhn Song (5 out of 7 patents)

8. Hee Kyu Lee (5 out of 5 patents)

9. Hyung-Gun Kim (5 out of 5 patents)

10. Dong-Heon Baek (5 out of 5 patents)

11. Jong Sung Koh (5 out of 19 patents)

12. Dong-Sik Jung (4 out of 5 patents)

13. Sunhwa Chang (4 out of 4 patents)

14. Yung-Geun Choi (3 out of 3 patents)

15. Hong Woo Kim (3 out of 7 patents)

16 patents: Sort by Forward Citations

1. 12350272 - Pyridopyrimidinone derivatives for use as AXL inhibitors (2025-07-08),

2. 11731969 - Crystal polymorph of 8-bromo-2-(1-methylpiperidin-4-ylamino)-4-(4-phenoxyphenylamino)pyrido[4,3-d]pyrimidin-5(6H)-one hydrochloride and method for preparing same (2023-08-22),

3. 11370796 - Substituted pyrazoles as LRRK2 inhibitors (2022-06-28),

4. 9212178 - Substituted pyrimidine compounds and their use as SYK inhibitors (2015-12-15),

5. 8877763 - Substituted pyridopyrimidine compounds and their use as FLT3 inhibitors (2014-11-04),

6. 8871778 - Substituted pyrimidine compounds and their use as SYK inhibitors (2014-10-28),

7. 8629132 - Kinase inhibitors (2014-01-14),

8. 8404677 - Kinase inhibitors (2013-03-26),

9. 8333998 - Herbal mixture extract of rehmanniae radix preparata and acanthopanacis cortex and a composition comprising the same for prevention and treatment of osteoporosis (2012-12-18),

10. 8227456 - Pharmaceutical composition for preventing and treating metabolic bone diseases containing alpha-arylmethoxyacrylate derivatives (2012-07-24),

11. 8053001 - [object Object] (2011-11-08),

12. 7879835 - Pharmaceutical composition for preventing and treating metabolic bone diseases containing alpha-arylmethoxyactylate derivatives (2011-02-01),

13. 7811612 - Herbal mixture extract of notoginseng radix, rehmanniae radix preparata and acanthopanacis cortex and composition comprising the same for prevention and treatment of arthritis (2010-10-12),

14. 7794760 - [object Object] (2010-09-14),

15. 7595068 - Composition comprising Notoginseng radix extract for preventing and treating of arthritis as an effective ingredient (2009-09-29),

Company Overview

Oscotec Inc. is a South Korean biotechnology company based in Seongnam, specializing in the development of innovative therapeutic solutions. The organization focuses on research and development in the fields of drug discovery and biopharmaceuticals, aiming to address unmet medical needs through advanced technologies. Oscotec's expertise encompasses various therapeutic areas, including oncology and autoimmune diseases, positioning it as a key player in the global biopharmaceutical landscape.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

16 Patents

#46 in Seongnam

#746 in South Korea

#37,887 in the World

Seongnam, South Korea

Oscotec Inc.

Forward Citations = 26

55 inventors:

Se-Won Kim (11 out of 16 patents)

Jang-Sik Choi (7 out of 7 patents)

Jaekyoo Lee (7 out of 12 patents)

4. Jung-Keun Kim (7 out of 7 patents)

5. Seon-Yle Ko (7 out of 7 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Oscotec Inc.. Retrieved from https://idiyas.com/company/oscotec

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…